Skip to main content
Back
Watch Compare

MUSTANG BIO, INC.

Data quality: 83%
MBIO
Nasdaq Manufacturing Chemicals
$0.74
▼ $0.01 (-0.93%)
Mkt Cap: 5.63 M
Price
$0.74
Mkt Cap
5.63 M
Day Range
$0.74 — $0.75
52-Week Range
$0.53 — $7.00
Volume
9,044
Open $0.74
50D / 200D Avg
$0.89
16.56% below
50D / 200D Avg
$1.33
44.18% below

Quick Summary

Key Takeaways

Negative free cash flow of -5.26 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-30.34%
Above sector avg (-53.47%)
ROIC-29.64%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio2.05
Interest CoverageN/A

Valuation

PE (TTM)
-2.93
Below sector avg (-1.47)
P/B Ratio0.58
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -2.9 -1.5
P/B 0.6 1.6
ROE % -30.3 -53.5
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

ETFs Holding This Stock

DLHAX DLHAX
0.00% weight
DLRHX DLRHX
0.00% weight
DLHIX DLHIX
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -1.92 M
ROE -30.34% ROA -11.86%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -5.26 M
ROIC -29.64% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 2.05
Interest Coverage N/A Asset Turnover N/A
Working Capital 9.92 M Tangible Book Value 9.77 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2.93 Forward P/E N/A
P/B Ratio 0.58 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -93.49%
Market Cap 5.63 M Enterprise Value -13.35 M
Per Share
EPS (Diluted TTM) -0.39 Revenue / Share N/A
FCF / Share -0.69 OCF / Share -0.69
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 274.02%
SBC-Adj. FCF -5.41 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -1.92 M -15.75 M -51.60 M -77.53 M -66.37 M
EPS (Diluted) -0.39 -38.57 -6.00 -0.75 —
Gross Profit — — — — —
Operating Income -2.43 M -16.25 M -49.26 M -76.16 M -66.72 M
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — 5,000.0 4.11 M 3.36 M —
Income Tax 27,000.0 — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 17.59 M 9.31 M 17.74 M 92.42 M 125.17 M
Total Liabilities 8.06 M 13.18 M 17.62 M 46.15 M 12.77 M
Shareholders' Equity 9.53 M -3.87 M 123,000.0 46.27 M 112.40 M
Total Debt — — — — —
Cash & Equivalents 17.27 M 6.84 M 6.23 M 75.66 M 109.62 M
Current Assets 17.59 M 8.61 M 11.35 M 78.85 M 111.71 M
Current Liabilities 7.91 M 12.61 M 15.37 M 15.11 M 10.82 M